AI has become the newest battleground on studio lots and union floors, pitting visions of cheaper, faster production against fears that the very soul of filmmaking is up for negotiation. Movie studios ...

Instagram is expanding its Your Algorithm feature to the main feed, enabling users to view and modify the topics that drive their content recommendations The update utilizes large language models to ...

As its traffic continues to climb, alternative search engine DuckDuckGo is leaning into anti-AI sentiment with the launch of new browser extensions that allow users to set its no-AI search experience, ...

Over the weekend, I got a message from a tech company CEO outlining his total ban on AI across his organization. There are no exclusions. It is not limited to generative AI. It is not temporary. It is ...

Rob Williams knows how to pitch Jeff Bezos: You write a press release as if your product has already been built. Bezos reads it and gives a thumbs up or down. Williams went through this process a lot ...

Google is testing a toggle that lets you control whether a site appears in AI Overviews and AI Mode. New dedicated performance reports will show impressions from generative AI Search features. Both ...

You can listen to more articles from The Conversation, narrated by Noa, here. Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using ...

Section 1. Purpose. The United States continues to lead the world in Artificial Intelligence (AI) because of the enormous talent and innovation of our AI industry, and because we refuse to stifle this ...

Dataland, the world’s first AI arts museum, opens in Frank Gehry’s Grand LA with an immersive rainforest journey using biometrics, scent, sound and light to transform how visitors experience nature ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Spencer Judge discusses the architectural ...

The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no ...